The development of donor specific human leukocyte antigen (HLA) antibodies (DSA) as already been identified as a risk factor for graft dysfuntion and poor survival in teh context of lung transplantation (LuTx), but available evidence is not conclusive. The aim of the study was to evaluate the possibly existing correlation between pre-existing and/or post transplant developing DSA and recipients' outcome.
Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes? / E. Benazzi, L. Morlacchi, A. Cannavò, L. Rosso, A. Palleschi, V. Rossetti, I. Righi, S. Passamonti, B. Dalpedri, E. Longhi, M. Cardillo, P. Tarsia. ((Intervento presentato al convegno ISHLT Annual meeting and Scientific Sessions tenutosi a Orlando nel 2019.
Titolo: | Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes? |
Autori: | |
Data di pubblicazione: | apr-2019 |
Settore Scientifico Disciplinare: | Settore MED/21 - Chirurgia Toracica |
Tipologia: | Conference Object |
Citazione: | Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes? / E. Benazzi, L. Morlacchi, A. Cannavò, L. Rosso, A. Palleschi, V. Rossetti, I. Righi, S. Passamonti, B. Dalpedri, E. Longhi, M. Cardillo, P. Tarsia. ((Intervento presentato al convegno ISHLT Annual meeting and Scientific Sessions tenutosi a Orlando nel 2019. |
Appare nelle tipologie: | 14 - Intervento a convegno non pubblicato |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
ISHLT 2019 (antihla antibodies...).pdf | Publisher's version/PDF | Open Access Visualizza/Apri |